TG Therapeutics

is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.

 

Click for full image >>

For Investors

NASDAQ: TGTX
Stock Quote at: Feb 28, 12:15PM EST

Last: $5.72

Change: ($0.12) (2.14%)

Quotes provided by Google - Min 15 minute delay